Stockreport

Corcept Primed For An Upside EPS Surprise [Seeking Alpha]

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF Approval of the company's Relacorilant medication by the FDA will essentially resolve any generic threat of its current medication, Korlym. Corcept's patient base has [Read more]